What’s Next? Five Things To Look Out For In July
Teva Opioids Trial In San Francisco To Close; More Vasostrict ANDAs Anticipated
Executive Summary
This month, long-awaited new pricing measures in Canada will come into force, while several trials will either kick off or end, including a liability opioids case involving Teva in San Francisco and Hatch-Waxman litigation over Otsuka/Lundbeck’s Rexulti.